Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Advanced Biological Innovation and Manufacturing (CABIM) is a non-profit organization based in Watertown, Massachusetts, dedicated to accelerating the development and production of cell and gene therapies. Founded through a landmark collaboration between Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Cytiva, and Alexandria Real Estate Equities, the center provides state-of-the-art cleanroom facilities and R&D labs. It serves as a hub for academic and industry partners to bridge the gap between laboratory discovery and clinical-scale manufacturing. CABIM focuses on process development, viral vector production, and advanced cell therapy manufacturing to streamline the path to patient care. By offering shared resources and technical expertise, the center aims to reduce the barriers to entry for innovative biological treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Advanced Biological Innovation.